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The infectious agent of malaria, the Plasmodium falciparum
sporozoite, is injected into the skin by the mosquito as it
probes for a blood vessel from which to feed. Few sporo-
zoites are injected directly into the circulation via the mos-
quito bites. The sporozoite efficiently leaves the skin,
localizes in the liver, and invades hepatocytes. One single
Plasmodium sporozoite in one liver cell multiplies into tens
of thousands of exoerythrocytic merozoites, each of which
is able to invade a red blood cell, initiating the stage of the
infection that causes the malarial disease. A percentage of
asexual parasites convert to gametocytes, which are able to
infect mosquitoes that transmit the infection to other
humans. How the sporozoite travels from the skin to the
liver, localizes to the liver, and invades hepatocytes are
mysteries that are beginning to be elucidated. A recent
study describes a new phase in this process in which sporo-
zoites migrate through several cells, including hepatocytes,
before settling into a hepatocyte for multiplication [1].
Malaria was described as a disease by Hippocrates in the
fourth century BC, but the parasitic nature of the infection
was not revealed until 1880 by Laveran. Ronald Ross, a
British scientist working in India in 1897, then discovered
that mosquitoes were vectors of malaria. He observed
sporozoites of avian malaria within Culex mosquitoes and
found that these sporozoites produced chicken infections;
then workers in Italy showed the critical role of Anopheles
mosquitoes in human malaria. Because malaria infects red
blood cells, easily identified in stained blood films in
patients, it was natural to assume that sporozoites directly
invaded these cells. Schaudinn, in 1903, claimed he saw a
sporozoite enter a red blood cell, a misconception that
held up the pursuit of the events that take place before
red blood cell invasion. Sporozoites of avian malaria were
shown to multiply first in macrophages within the skin,
then in other organs. The site for sporozoite development
in primate malaria was unveiled much later from studies
with monkey malaria. Shortt and Garnham [2] searched for
the elusive exoerythrocytic merozoite (EE) forms in tissue
sections from every organ of a monkey that had been
bitten by thousands of P. cynomolgi-infected mosquitoes
and then injected intravenously with tens of millions of
sporozoites. Only liver cells were infected.
We shall briefly discuss the invasion of hepatocytes by
sporozoites in malaria in a broader context of how parasites
enter cells during different stages of their life cycle. All
protists of the phylum Apicomplexa are defined by a set of
organelles, called rhoptries and micronemes, at the apical
end of these parasites. The phylum includes important
pathogens of humans such as Plasmodium spp., Toxoplasma
gondii and Cryptosporidium parvum as well as members
exclusively parasitic in animals such as Eimeria, Neospora,
and Sarcocystis. In Plasmodium, there are three invasive
stages involving the apical organelles: ookinetes, which
invade the mosquito midgut epithelium; sporozoites, which
invade the mosquito salivary glands and host hepatocytes;
and merozoites, which invade host red blood cells.
The first mechanism of invasion described was for the ery-
throcytic merozoites [3]. The merozoite contacts the red
blood cell surface, reorients with its apical end against the
cell, forms a junction with the cell, and pulls itself into
the cell in a vacuole formed as the merozoite enters. The
vacuole originates from the host plasma membrane, and its
formation is presumably induced by rhoptry proteins [4].
Evidence for the critical nature of the junction derived
first from studies of P. knowlesi, which was shown to require
the expression of Duffy blood group determinants for both
junction formation and invasion of red blood cells [5]. The
parasite receptor that binds to the Duffy blood group
determinants localizes in the micronemes [6], an organelle
that also contains other receptors such as EBA-175, a
Duffy-like molecule of P. falciparum, and the circumsporo-
zoite protein of sporozoites.
Motility and cell invasion by Apicomplexan parasites are
exquisitely sensitive to cytochalasins, implying that both
processes are dependent on actin filaments in the parasite.
The essential role of parasite but not host cell actin in
powering motility and invasion was definitively shown in
the case of T. gondii using a combination of host and para-
site mutants that were resistant to cytochalasin D [7]. A
variety of myosin isoforms has also been described in Api-
complexans, and indirect evidence indicates that they serve
as motors for propelling cell locomotion and entry [8].
Kappe et al. [9] have identified the thrombospondinrelated
anonymous protein (TRAP) as the critical membrane
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protein that interacts with the skeletal proteins in malarial
sporozoites and in T. gondii.
The ookinete, the invasive stage in the mosquito midgut,
traverses the peritrophic membrane in the mosquito
midgut by secreting chitinase. It then enters the apical
side of epithelial cells, and leaves the basal side to form an
oocyst — the extracellular, proliferative form of the para-
site in which sporozoites are formed. Despite the fact that
it has been over 100 years since Ross described the inva-
sion of epithelial cells, there remains controversy as to how
the ookinetes invade and whether they invade a special
subpopulation of epithelial cells [10,11]. Although invasion
is critical to move the ookinetes into the next compart-
ment for their development, it is in no way critical for sig-
naling development. This stage of the invasion process can
be bypassed, because ookinetes inoculated directly into
the hemolymph develop into sporozoites and ookinetes
can also develop into sporozoites in vitro [12].
Sporozoites released from the oocyst in the mosquito
hemocele must invade the salivary glands to reach the next
host through a mosquito bite. Binding to specific receptors
on the salivary glands seems necessary, because  antisporo-
zoite antibodies inhibit salivary gland invasion [13]. Sporo-
zoites invade the salivary gland epithelial cells, apical end
first, within a vacuolar membrane and appear to have a
junction with the epithelial cell membrane at one end
[14]. The vacuolar membrane is then rapidly lysed so that
the sporozoites lie free within the cytoplasm.
Parasites delivered by mosquito bites are usually not
injected directly into the circulation (Figure 1). As the
mosquito searches for a blood vessel, it releases various
vasodilators to increase its chance of finding a vessel;
sporozoites, if present, are deposited in the skin as the mos-
quito hunts for a vessel [15]. When the mosquito enters a
blood vessel, it ingests blood, and no longer releases saliva
or sporozoites. Mice bitten by mosquitoes on the ears are
infected less frequently if the site is excised within five
minutes after feeding [16], providing further evidence that
sporozoites are not released after the mosquito enters a
vessel. How sporozoites leave the skin is unknown. The
recent study by Mota et al. [1] demonstrates that sporo-
zoites can travel through an epithelial layer in vitro, a
mechanism that may permit the passage of sporozoites
through vessels in the skin.
After sporozoites leave the skin and enter the circulation,
they efficiently localize to the liver and invade hepatocytes.
The efficiency of liver infection in the natural host can be
high, as is the case for P. berghei sporozoites in the tree rat;
the efficiency of liver infection by these sporozoites in
mice, however, is quite different (50% and 1–3%, respec-
tively) [17]. This efficiency difference was found to result
from a failure of development of sporozoites in mouse hepa-
tocytes, not a failure of infection [18]. Mice, although not
the natural host for P. berghei and therefore less efficient, are
used extensively for vaccination experiments. The sporo-
zoite binds to specific receptors on liver cells that include
glycoaminoglycan chains of heparan sulfate proteoglycans
[19,20]. The co-receptor on sporozoites involves, in part, the
thrombospondin domains on the circumsporozoite protein
[21] and on TRAP [22]. The thrombospondin domain binds
specifically to heparan sulfate proteoglycans on hepatocytes
in the region in apposition to sinusoidal endothelia and
Kupffer cells (see Figure 2 for diagram of liver structure). 
Figure 1
Plasmodium-infected, female anopheline mosquitoes inject sporozoites
through the proboscis (arrow) into the skin, together with saliva, which
also contains vasodilators and anticoagulant molecules (a). The
mosquitoes probe the skin to find and enter a blood vessel and
immediately begin to suck blood (b). The arrows in (b) show the
direction of blood flow from the vessel through the proboscis when a
mosquito enters the vessel and sucks blood. Most sporozoites are
deposited in the skin; few are inoculated directly into the circulation.
Because the sporozoites have to traverse the endothelial cells to reach
hepatocytes, an obligatory step for parasite development, these
parasites must pass through other cells, as shown by Mota et al. [1].
(Image courtesy of D. Bliss.)
Sporozoites
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How then does the sporozoite reach hepatocytes? Do
sporozoites pass through fenestrations in the endothelium
in portal veins, or do they enter the space of Disse by tra-
versing Kupffer cells? The rapidity with which sporozoites
that are inoculated intravenously by syringe can enter
hepatocytes might argue that they invade directly by
migrating through the endothelial fenestrations that may
expose the receptor-laden hepatocytes to the portal circu-
lation (Figure 2). This passage through fenestrations, how-
ever, has never been observed. 
Meis et al. [23] observed sporozoites passing through
Kupffer cells in a vacuole, passing into the space of Disse.
Recent work by Pradel and Frevert [24] supports the
notion that sporozoites use Kupffer cells as a gate to the
liver: the parasites bind to and actively invade Kupffer
cells, but not sinusoidal endothelia in vitro. Upon invasion,
sporozoites enter a vacuole in Kupffer cells that does not
fuse with lysosomes, thus explaining why they are not
being degraded. If this is the mechanism for entering the
liver, how does the sporozoite recognize the Kupffer cells
to reach the hepatocytes efficiently? Notably, avian and
reptilian malaria species develop inside Kupffer cells, so
that, conceivably, the mammalian species may have pre-
served this recognition mechanism. One possible model is
that mammalian malaria sporozoites are initially arrested in
the sinusoid by binding to the liver- specific heparan
sulfate proteoglycans protruding into the sinusoidal lumen
through the endothelial fenestration and glide with the
bloodstream towards the next Kupffer cell, which they tra-
verse to obtain access to the space of Disse.
Mota et al., in the recent Science paper [1], address the
mechanism of invasion of hepatocytes. They observed inva-
sion in vitro of hepatoma cells and noted that sporozoites
passed through the cells in a similar manner as that
described by Vanderberg et al. [25]. The use of a marker for
accessibility of large molecules (fluorescent dextran) to the
cytoplasm and markers for the plasma membrane demon-
strated that sporozoites in cells with dextran in the cyto-
plasm were not surrounded by the host plasma membrane.
In cells surrounded by the host plasma membrane viewed
24 hours later, no dextran was seen spread through the
cytoplasm. This indicated that sporozoites pass through
many cells without having entered into a vacuole. In a few
cells, sporozoites had invaded within a vacuole, and these
were the only sporozoites that developed into EE forms,
the multiplying parasite. Mota et al. [1] injected fluorescent
dextran with the sporozoites in vivo and noted fluorescent
dextran in the liver cells near the developing EE forms.
They concluded that the parasite first passed through a
number of hepatocytes before invading another hepatocyte
by a vacuolar mechanism that led to EE formation.
What is the meaning of passing through cells outside of a
vacuole before invading within a vacuole to develop into
EE forms, and how does this invasion within a vacuole
occur? One possibility is that the parasite surface changes
to expose other receptors that are critical for invasion. In
the case of P. vivax merozoites, the parasite only invades
Duffy-positive reticulocytes. Invasion requires two differ-
ent co-receptors — one for Duffy-positive cells and one for
reticulocytes. Is it possible that, for Plasmodium sporozoites,
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Figure 2
Sporozoites, as they circulate through the
sinusoids of the liver, must cross to the
hepatocytes where they undergo
development. It is unknown whether they pass
through the Kupffer cells within a vacuole or
through the fenestrations in the endothelia.
(Image courtesy of D. Bliss.) Hepatocyte
Endothelial
cell
Fenestration
Kupffer cell
Hepatocyte
one receptor brings the parasite to the liver, and two
receptors allow invasion within a vacuole? Is this invasion
within a vacuole determined by a moving junction similar
to the events in the red blood cell and what appears to
happen within the salivary glands? The mystery still
remains why the parasite needs to invade hepatocytes by
one method before it can have a productive infection that
leads to EE forms.
These critical details in parasite invasion remain to be
determined in the many phases of the parasite life cycle
and may play an important role in vaccine design to block
invasion. For example, at least in the mouse model, high
doses of passively transferred anti-circumsporozoite anti-
bodies will block infection by sporozoites inoculated intra-
venously but not through mosquito bites [26]. Protection
against mosquito challenge was shown, however, when
high anti-circumsporozoite antibodies were induced by
vaccination with the hybrid of circumsporozoite repeats
[27] or the circumsporozoite protein [28] and the hepatitis
B virus nucleocapsid antigen. Studies of the normal physi-
ology of sporozoites in the skin, such as the one by Mota
et al. [1], will inform the design of sporozoite vaccine
studies that may be more relevant to protection from
natural mosquito challenge.
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